Stada Arzneimittel AGSAZX.N:GER

37.05
0.315 / 0.84 %
317.36k
11.97%
0.909
Close in EURToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Apr 29 2016 16:35 BST.

Summary

On Friday, Stada Arzneimittel AG (SAZX.N:GER) closed at 37.05, 1.67 % below its 52-week high of 37.68, set on Apr 14, 2016.

52-week range
Today
28.05
Feb 09 2016
37.68
Apr 14 2016
Markit short selling activity
Low
Medium
High
Open37.20
Day high37.35
Day low36.67
Bid37.02
Offer37.12
Previous close37.37
Average volume299.28k
Shares outstanding62.34m
Free float59.19m
P/E (TTM)20.58
Market cap2.31bn EUR
EPS (TTM)1.80 EUR
Annual div (IAD)0.5154 EUR
Annual div yield (IAD)1.39%
Div ex-dateJun 04 2015
Div pay-dateJun 04 2015
Next div ex-dateJun 10 2016
Next div pay-dateJun 10 2016
Data delayed at least 15 minutes, as of Apr 29 2016 16:35 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Stada Arzneimittel AG+0.32 %+8.91 %+7.02 %+11.97 %+24.02 %
DEUTSCHE BORSE DAX INDEX-3.22 %+1.53 %-7.48 %-12.19 %+33.60 %
DE/HEALTH CARE-6.91 %-1.28 %-15.13 %-16.21 %+43.99 %
DE/PHARMACEUTICALS-8.38 %-1.23 %-19.07 %-27.69 %+42.82 %
Data delayed at least 15 minutes, as of Apr 29 2016 16:35 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.